Episoder
-
Over the course of this season, one thing has kept coming up across all the episodes - the power of big data in health tech. From its uses in the current AI revolution, to universal health records and even in new sustainable practices, the way in which huge data sets are allowing health practitioners to create new products and services is as fascinating as it is exciting.
So in this season’s final episode, we take a look at the kind of utopian world that could exist when data is harnessed properly in the entire healthcare ecosystem, and what the roadmap to getting there looks like.
Find out more on this week’s episode of Invent Health from TTP.
This Week’s Guests:
Giovanna Jaramillo-Gutierrez
Giovanna is an epidemiologist researcher and a data scientist who began work as a molecular biologist, before moving into epidemiology. She works at the intersection of epidemiology and AI and is passionate about the development of ethical, human-centered, AI-based products and services. She has worked across the globe for various international organisations including the WHO and Eticas Consulting, amongst others. Get in touch with Giovanna on LinkedIn
Anthony Sitaš
Anthony is a consultant at TTP who works across digital health strategy and design and product development partnerships. His focus lies within the areas of psychology, neuroscience, clinical decision support systems and algorithmic explainability, and he is a passionate advocate of both decentralised Healthcare and Preventative and Precision Medicine. Get in touch with Anthony on LinkedIn
The Technology Partnership is where scientists & engineers develop new products and technologies that bring innovation & value to clients.
Find out more about our work here: https://www.ttp.com/
-
Speed is not normally something you would associate with the highly regulated world of health tech. “Rapid” time frames tend to be in the space of 3-5 years. But the Covid panic changed this - the war footing it caused brought times down enormously. It’s something that TTP played a hand in as well with Covent, TTP’s rapid manufacture ventilator for COVID-19 patients. So what can we learn from this period to bring to normal times? How can health tech practitioners work with regulators and the NHS to ensure new innovations move from idea to impact as quickly as possible? How can we achieve truly rapid innovation?
Find out more on this week’s episode of Invent Health from TTP.
This Week’s Guests:
Dr. Edwin Stone
Dr. Edwin Stone is a consultant at TTP who now leads Cellular Origins, a TTP spin-out created to enable scalable and cost-effective manufacture of cell and gene therapies. Before this, he worked on some of the earliest EMA-approved cell therapies and has been involved in the development of over 10 novel cell therapy automation platforms. He was also closely involved in Covent, TTP’s rapid manufacture ventilator for COVID-19 patients. Connect with Edwin on LinkedIn.
Luella Trickett
With over 25 years' experience in the pharmaceutical and HealthTech industries, Luella’s career has seen her hold numerous specialist manufacturing and commercial roles, with responsibility for a range of product portfolios across the HealthTech spectrum within the UK, Europe, Middle East and Africa. In 2019 she joined the ABHI as their director of value and access, an organisation who represent and support the entire industry to stakeholders, including the government, NHS, and regulators. Connect with Luella on LinkedIn.
The Technology Partnership is where scientists & engineers develop new products and technologies that bring innovation & value to clients.
Find out more about our work here: https://www.ttp.com/
-
Mangler du episoder?
-
There’s a multitude of ways to treat Cardiac issues, and it’s about more than just health tech. While technologies that intervene after a cardiac event has taken place are coming on leaps and bounds - from ablation catheters to pacemakers - preventative measures are seen by many as the way forward. Whether it is improved sensing technologies, the rise of telehealth, or even promoting good lifestyle factors, stopping cardiac issues even happening in the first place is a first port of call for many clinicians. But which is more significant? What’s the way forward? And how do we keep patients with cardiac issues out of the hospital?
Find out more on this week’s episode of Invent Health from TTP.
This Week’s Guests:Professor Stephen Leslie
Professor Stephen Leslie has been an interventional cardiologist with NHS Highland since 2006, and has research interests that include heart failure and remote and rural service provision. Alongside his clinical work, Stephen is also an honorary professor with The University of the Highlands and Islands and The University of Stirling. Connect with Stephen on LinkedIn.
Simon Calcutt
Simon has been a TTP consultant for the past 8 years, and across that time, he’s been working on medical devices from drug delivery to surgical systems and active implantable devices. His current focus is around implantable devices and utilising sensor technology for real time or near real time monitoring, enabling more personalised medicine, remote patient monitoring and improved standards of care, with cardiac health as one of his main specialities. Connect with Simon on LinkedIn.
The Technology Partnership is where scientists & engineers develop new products and technologies that bring innovation & value to clients.
Find out more about our work here: https://www.ttp.com/
-
Trust in healthcare is one of the highest for any industry, but it’s a different story for the technology sector. People will inherently trust their doctor, but social media, or medical advice from the internet? Much less so.
But as healthcare and technology become ever more entwined, how do those designing healthcare’s digital products ensure those using them will trust them? What will the consequences of falling trust in technology mean for health tech?
And what does it take to make you trust someone in general?
In this episode of Invent: Health, we speak with Dan Lock from TTP and Jordan Abdi from Picnic Health, to unlock the principles of trust and find a paradigm for what this will look like in the future of healthcare.
Find out more on this week’s episode of Invent Health from TTP.
This Week’s Guests:Dan Lock - Dan is a principal consultant in human factors at TTP, where he has been for the past 6 years. His background is in psychology with a masters in Ergonomics and Human-Computer Interaction. His primary interests are around human performance, usability, behaviour change, and user experience in medical technology, and he also has a particular focus on supporting design for engagement. Connect with Dan on LinkedIn
Jordan Abdi - Jordan is a World Economic Forum Global Shaper and Schwarzman Scholar who is passionate about preventative health. A medical doctor by background, he has 8+ years' experience working in the health technology sector, and has co-founded think tanks, founded health tech companies, and more. He is currently the Life Sciences Business Development Lead at Picnic Health, a company who tracks health records for patients across the U.S. Connect with Jordan on LinkedIn
The Technology Partnership is where scientists & engineers develop new products and technologies that bring innovation & value to clients.
Find out more about our work here: https://www.ttp.com/
-
Medical imaging technologies have long been dominated by big, expensive machines that take up their own room within hospitals. The level of detail they can give is extensive and vital, and they are now even developing new fusion technologies that can combine nuclear, ultrasound, and MRI technologies together.
But there is a new range of technologies coming into the market which are changing the way we think about imaging. These devices are more portable, and cheaper, allowing true point of care for patients, while also unlocking imaging in new realms of healthcare.
In this episode of Invent Health, we speak with George Wylde of TTP and Paul Cload of Serac Imaging Systems, to assess the state of play in medical imaging today, to see the benefits and disparities between the new range of machines and the ones which have previously dominated the market.
Find out more on this week’s episode of Invent Health from TTP.
This Week's Guests:
Paul Cload - Dr. Paul Cload is the chief marketing officer of Seracam Imaging Systems. With over 30 years of experience in the global pharmaceutical medical device and diagnostics industries, Paul brings insight from all areas of the bioscience space to his work with Serac. He has a broad knowledge of multiple therapeutic areas including infectious diseases, cardiovascular disease, oncology, diabetes, and musculoskeletal disease.
George Wylde - George Wylde is a technical consultant at TTP where he combines a passion for medical imaging and sensing inside the body with a love of building things. His experience has spanned from the development of a gamma imaging system for nuclear medicine to a smart orthopaedic implant. Prior to TTP George worked at a family-run scientific instrument company in Sussex developing an instrument to be flown on the next generation of ESA’s meteorological satellites (MetOP-SG MWS). He holds a Biophysics PhD in Embryonic Stem Cell Research from the University of Cambridge.The Technology Partnership is where scientists & engineers develop new products & technologies that bring innovation & value to clients.
Find out more about our work here: www.ttp.com -
Sustainability is a word now ubiquitous in healthcare. But too often it is thought about with a short-sighted lens, promoting potentially superficial changes in micro areas over innovations that would reduce healthcare’s carbon footprint on a macro level. So how can we solve this?
What could a new paradigm for discussing sustainability in healthcare look like?
In this episode of Invent Health, we meet the people seeking to create one, by focusing on the wider impact of medical devices to keep people out of hospital, with the potential to reduce carbon footprints on a huge scale.
Find out more on this week’s episode of Invent Health from TTP.
This Week’s Guests:
Ama Frimpong - Ama Frimpong is the head of product development at 52 North Health - a company that works across the medical device space as they seek to improve health outcomes by reinventing care pathways using affordable, human-centred technologies. With a materials and mechanical engineering background, Ama also has a real grounding in medical devices, from laparoscopic instruments to orthopedics. She was also recently awarded the hugely prestigious ‘young woman engineer of the year’ award for 2022 for her work with 52 North.
Freddie Scott - Freddie Scott is a strong proponent of every industry playing an active role in tackling Climate Change. At TTP, he was part of the passionate sustainability team, who have developed a method for assessing the environmental impact of medical devices in the context of their wider care pathway. By exploring the downstream emissions of products, the scope for design interventions to reduce their environmental impact becomes increasingly broad and impactful; enabling the decarbonisation of healthcare in the shortest time possible.
The Technology Partnership is where scientists & engineers develop new products & technologies that bring innovation & value to clients.
Find out more about our work here: www.ttp.com -
Neurological disorders have a really significant patient burden, with some estimates suggesting the impact as many as 1 billion people across the globe. But simultaneously, these are diseases which are both challenging to treat and still remain relatively poorly understood.
Snapshots of the brain have been available through imaging technologies for a while, but coming up with devices that are able to monitor the brain in real time has proved a huge challenge.
Today we ask, what will improvements to continuous monitoring devices enable for the diagnosis and treatment of neurological disorders?
In the second episode of Invent:Health Season 2, Matt Parker speaks to Alex Stokoe, a neurotechnology consultant at TTP, and Professor Martha Morrell, Clinical Professor of Neurology at Stanford University
This Week's Guests
Alex Stokoe - Alex Stokoe is a neurotechnology consultant at TTP. Working closely with clients, Alex has worked on and led the product development of several medical devices and specializes in next-generation modulation systems, across biosensing, digital health, and neurotechnology markets.Martha Morrell - Professor Martha Morrell is the Clinical Professor of Neurology at Stanford University. As someone who has spent their entire career working at the forefront of this field, Martha's previous experience is distinguished. Having served in various positions across the university since joining in 2004, Martha has authored and co-authored more than 150 publications. Martha is also the Chief Medical Officer at NeuroPace, a company that has developed a responsive neurostimulator for the treatment of medically uncontrolled partial seizures.
The Technology Partnership is where scientists & engineers develop new products & technologies that bring innovation & value to clients.
Find out more about our work here: www.ttp.com -
In this first episode of Invent:Health Season 2, Matt Parker speaks to Chris Dawson, Head of Biosensing at TTP, and Dr. Andrew Chapman, CEO, and Co-Founder of Carbometrics, to explore how patients can be taken out of this monitoring-delivery loop and what technologies are out there that can automate the process entirely.
This Week's Guests
Chris Dawson - Dr. Chris Dawson is a mechanical engineer who leads the biosensing team at TTP. The team works with clients to leverage advances in biosensing technology to develop products that support patients in managing and treating a wide range of diseases. They develop sensing solutions from short-term minimally invasive to long-term fully implantable, all with challenging requirements for biocompatibility, hermeticity, form-factor, wireless power & comms, and integrate a broad range of sensing modalities from electrical and electrochemical, through to ultrasonic and optical.Andrew Chapman - Dr. Andrew Chapman is a scientist and entrepreneur who for over a decade, has designed and led interdisciplinary commercial and academic programs across a whole range of different scientific disciplines. Andrew is currently the CEO and co-founder of Carbometrics, a company whose revolutionary biomimetic glucose binding molecules have made them one of the most exciting companies working in this space.
The Technology Partnership is where scientists & engineers develop new products & technologies that bring innovation & value to clients.
Find out more about our work here: www.ttp.com -
Today we launching the trailer for the Invent Health podcast. Each week we're going to be joined by the top scientists, engineers, and academics working to give you a behind-the-scenes look at the world of health tech.
-
Doing what’s good for you should seem like second nature, so why is it that we as humans so often don’t do things which we know will be effective when it comes to our own health and wellbeing? From difficulties in quitting smoking to the 25% of prescriptions in the UK that are left unfilled, medical non-adherence has profound effects on the health of a population, and it’s also one of the trickiest realms for health practitioners to deal with. How do you literally change someone’s behaviour if they already know they’re doing themselves harm?
Find out on this week's episode of Invent: Health from TTP.
This Week's Guests
Paul Upham is the Head of Smart Devices at Roche / Genentech and has over 20 years of experience in medical technology and digital health in R&D as well as global marketing and product management roles, including leading the development of the world's first prescription digital therapy for type 2 diabetes, Bluestar, from WellDoc.
https://www.linkedin.com/in/paulupham/Dan Lock is a consultant in psychology and human factors at TTP. A psychologist by background, Dan leads on understanding the users of our products, exploring their motivations and figuring out those design features that translate into long-term adherence to medication.
https://www.linkedin.com/in/danlock/Dr. Olga Perski is an interdisciplinary scientist working at the intersection of behavioural science and digital health. She is a health psychologist by training and completed her PhD at University College London in 2018, with a thesis on the definition, measurement and promotion of user engagement with digital behaviour change interventions. She is a post-doc in the UCL Tobacco and Alcohol Research Group and a UCL Centre for Behaviour Change Associate. Her work is focused on the development and evaluation of digital interventions for smoking cessation and alcohol reduction.
https://www.olgaperski.com/The Technology Partnership is where scientists & engineers develop new products & technologies that bring innovation & value to clients.
Find out more about our work here: https://ttp.com/invent -
There is now a widespread awareness of the gravity of mental health issues in the general public, and equally in the world of healthcare. But in tandem with its rise we've seen the growth of the so-called "wellness industry", which too often promotes pseudo scientific solutions to the most complex of problems. So how is the health tech industry responding? What are the new frontiers for digital therapeutic care today, especially in the post-pandemic landscape?
Find out on this week's episode of Invent: Health from TTP
This Week's Guests
Adonis Bou Chakra is the Co-founder & CPO at Aepsy - designing & building products for better minds. He is a former global Design manager at Sennheiser with an MA Digital Management at Hyper Island.
https://www.adonisbc.com/Dr. Rashmi Patel is a MRC UKRI Health Data Research UK Fellow in the Department of Psychosis Studies at the Institute of Psychiatry, Psychology & Neuroscience, King's College London. He has a particular interest in the neurobiology of psychotic disorders and the role of health data research techniques such as extracting data from free text electronic health records (EHRs) using natural language processing to predict clinical outcomes and develop more effective treatment strategies.
https://www.kcl.ac.uk/people/dr-rashmi-patelJordan Abdi is the Strategy and Business Development Lead at Holmusk, a company building the largest Real-World Evidence platform, starting with behavioral health. He is also a World Economic Forum Global Shaper and a Schwarzman Scholar, who is passionate about preventative health. A medical doctor by background, he has close to a decade's experience working in the health technology sector.
https://www.linkedin.com/in/jordanabdi/The Technology Partnership is where scientists & engineers develop new products & technologies that bring innovation & value to clients.
Find out more about our work here.
https://ttp.com/invent -
Neurotech: what is it? Elon Musk’s brain implants that herald a dystopian sci fi future? Or life saving technology which will be able to cure a multitude of injuries: back pain, epilepsy, even paralysis. In this episode of Invent: Health, we take a look at the hype vs the reality in the thrilling field of neurotech, speaking to experts from TTP and beyond to break it down and find out about its history, its current applications and the incredible places it’s going in the future.
Find out more on this week's episode of Invent: Health from TTP.
This Week's Guests
Dr. Hannah Claridge is a Neural Interfaces specialist who co leads the neurotechnology team here at TTP. After a Master’s degree in Physics and a Ph.D. in Clinical Neurosciences from the University of Oxford, Hannah now specialises in neurotechnology and biosensing, developing clinical technologies for some of the world’s largest Med Tech companies and ambitious startups.
https://www.linkedin.com/in/hannah-claridgeDr Benjamin Metcalfe is an Assistant Professor at the University of Bath and a co-founder of the Centre for Biosensors, Bioelectronics, and Biodevices – the largest research centre of its type in England. Since starting in this role in 2016 he has published over 40 peer reviewed research papers and co-authored two books on neural interfaces. He holds a number of internal and external posts including as a trustee and non-executive director of both the Institute for Physics and Engineering in Medicine and the charity Designability. His research interests are in the areas of neural interfaces, neural computing, and signal processing.
https://researchportal.bath.ac.uk/en/persons/benjamin-metcalfeDr. Chris Dawson co leads the neurotechnology team at TTP with Hannah, working with ambitious clients across this field to develop novel enabling technologies and applying these to medical device development to help bring innovative new products to market. His degree and PhD are in mechanical engineering, and started his career working to develop automation systems to improve development and productivity in life science research, before moving into motorsport and working in the aero department at McLaren to design, develop, and test the aerodynamic elements of their formula one race car. This fast-paced design-develop-deploy environment was great preparation for moving into technology development at TTP, using deep science and engineering expertise to support clients in commercialising their ideas.
https://www.linkedin.com/in/chris-dawson-96908268/The Technology Partnership is where scientists & engineers develop new products & technologies that bring innovation & value to clients.
Find out more about our work here: https://ttp.com/invent -
Of all the senses, sight is perhaps our most important. The eye is one of the most incredible organs in nature: it enables us to perceive the world around us, understanding our world through images. And yet we only see a small aspect of reality. But the eye is important beyond just sight. It can also provide a window into our overall health, showing indicators for other things like alzeihmers and blood pressure. In this episode of Invent Health we breakdown the world of modern eyecare to find the ways that tech is improving our collective vision. We’ll hear about preventative procedures, cures to restore sight and the global discrepancies in treatment, alongside really getting to grips with what the future of healthcare looks like for perhaps our most vital organs.
Find out on this week's episode of Invent: Health from TTP.
This Week's Guests
Dr Jose-Alain Sahel is currently the chair of the Department of Ophthalmology at the University of Pittsburgh School of Medicine, director of the UPMC Eye Center, and the Eye and Ear Foundation Chair of Ophthalmology. Dr. Sahel previously led the Vision Institute in Paris, a research centre associated with the one of the oldest eye hospitals in Europe. He is a pioneer in the field of artificial retina and eye regenerative therapies and a member of the French Academy of Sciences.
https://en.wikipedia.org/wiki/Jos%C3%A9-Alain_Sahel
Pearse Keane is a consultant ophthalmologist at Moorfields Eye Hospital, London, and an associate professor at UCL Institute of Ophthalmology. In 2016, he initiated a formal collaboration between Moorfields Eye Hospital and Google DeepMind, with the aim of developing artificial intelligence (AI) algorithms for the earlier detection and treatment of retinal disease. In May 2020, he jointly led work, again published in Nature Medicine, to develop an early warning system for age-related macular degeneration (AMD), by far the commonest cause of blindness in many countries. In October 2019, he was included on the Evening Standard Progress1000 list of most influential Londoners and in 2020 he was listed on the “The Power List” by The Ophthalmologist magazine, a ranking of the Top 100 most influential people in the world of ophthalmology.
https://www.linkedin.com/in/pearse-keane-27074a6Catherine Wyman is a mechanical engineer by background who has developed a variety of medical devices and now leads TTP's eyecare team. She and the team focus on addressing unmet needs across ophthalmology, including in the areas we are discussing today.
https://www.linkedin.com/in/catherinewyman1The Technology Partnership is where scientists & engineers develop new products & technologies that bring innovation & value to clients.
Find out more about our work here: https://ttp.com/invent -
Humans are designed to make decisions in the now, not ones in the abstract long term. That’s why ‘cathedral thinking’ comes so hard to us - so it's understandable that making healthcare more sustainable is hard when its primary function is first and foremost to save lives today, not the planet tomorrow. It's easy to say you want to be more sustainable but when you're dealing with people's lives, does sustainability go out of the window? So what can we actually do? This episode of Invent: Health sees us explore the difficulties and challenges as healthcare industries try to become more sustainable.
Find out on this week's episode of Invent: Health from TTP.
This Week's Guests
Dr Michael Spiro is an anaesthetic and intensive care consultant at a London NHS teaching hospital. He has research interests in resource utilisation, enhanced recovery, innovation and sustainability in health care.
https://www.linkedin.com/in/mike-spiro-b40a3289/Dr Seema Gandhi is a professor in the department of anaesthesia and the medical director of sustainability at University of California, San Francisco Health System. Trained in India/ UK and the US, she has a global perspective of the practice of medicine and her research focused on decreasing carbon emissions and waste from healthcare. Dr Gandhi is involved in many initiatives focused on Reduction of single use devices, energy consumption and increasing sustainability focused education among healthcare providers.
https://anesthesia.ucsf.edu/people/seema-gandhiMaria Koijck is a Dutch artist and activist based in Groningen. Her artistic practise has focused on waste for many years. Whether it’s sculptures made from plastic bottles or tackling the issue of beachside pollution in countries as far afield as Sierra Leone, Maria’s work consistently takes aim at the unsustainable use of plastics while simultaneously opening up questions on how we might solve it.
https://www.mariakoijck.com/
https://www.youtube.com/watch?v=w28M7wjIr6EThe Technology Partnership is where scientists & engineers develop new products & technologies that bring innovation & value to clients.
Find out more about our work here: https://ttp.com/invent -
Surgical robotics are all the rage right now. Attracting huge investment from the biggest names in healthcare devices, the use of robots in surgery has the potential to change the industry in some really profound and exciting ways. However, some have criticised their implementation as an unnecessary expense when humans can perform these tasks just as well. This episode of Invent: Health will see our guests debate the efficacy and effectiveness of surgical robotics, seeing whether it’s the future of surgery, or just tech for tech’s sake. We’ll also look to the future to see how big an impact this is going to have in the coming years.
Find out on this week's episode of Invent: Health from TTP.
This Week's Guests
Dr. Paul Galluzzo has worked at TTP for the past 18 years. Before that, he did a PhD in mechanical engineering at Cambridge included building a robot to play the cello very accurately. Since then, he has worked across a wide range of markets and products at TTP, from gardening tools to DNA sequencing to inkjet. Inkjet was a fruitful pathway into ultrasound imaging, and ultrasound was in turn a gateway into medical technology about ten years ago. He now specialises mostly in the technology enablers in med-tech: navigation, visualisation, critical structure detection, energy delivery, implants, and of course surgical robotics.
https://www.linkedin.com/in/paul-galluzzo-1132113/Dr. Dwight Meglan, whose doctorate is in Mechanical Engineering, has worked on complex medical systems for more than 25 years as part of teams at a number of high technology medical startups as well as major medical device companies. As a result, he has worked on eight commercial surgical robots (NOTES, abdominal/thoracic, endovascular, electrophysiology, cardiac, gastrointestinal), multiple unique medical devices, as well as numerous surgical simulators combining real-time computational physics, VR/AR displays and custom haptics interfaces. His early work was in orthopedic biomechanics at Ohio State with a postdoc at Mayo Clinic where he turned down a tenure track position so he could stay involved in hands-on work.
https://www.linkedin.com/in/dmeglan/Dr. Mark Slack is the Chief Medical Officer and one of the co-founders of CMR Surgical, a global surgical robotics company that has developed Versius, a next-generation robotic system used to perform keyhole surgery. Today, Versius is being used in routine clinical practice to deliver high quality surgical care to patients around the world. Mark qualified in Medicine from the University of the Witwatersrand, Johannesburg and completed his postgraduate training in Obstetrics & Gynaecology at the University of Cape Town. During this time he was awarded the prestigious Daubenton Gold Medal from the College of Medicine of South Africa. Mark established the Urogynaecology service at Addenbrooke’s Hospital which has recognised accreditation by the British Society of Urogynaecology. He is also on the Editorial Board for the journal 'BMJ Surgery, Innovation and Health Technology'. He is a Fellow of the Royal College of Obstetricians and Gynaecologists and an official spokesperson for the college.
https://www.linkedin.com/in/mark-slack-3b8a2139/
The Technology Partnership is where scientists & engineers develop new products & technologies that bring innovation & value to clients.
Find out more about our work here: https://www.ttp.com/ -
Healthcare’s coming home, it’s coming home… Or is it? Recent years - and increasingly since COVID 19 - have seen healthcare moving into the home, with patients using more digital products to track their health from the comfort of their sofas. But why? What was the initial trigger for this? What are the risks and benefits? Will this see a dystopian world where only the rich see doctors in person or a complete democratisation of convenient healthcare? In this episode of Invent Health we break down healthcare in the home to see the benefits and blockers in the now and in the future.
Find out on this week's episode of Invent: Health from TTP.
This Week's Guests
Clayton Poppe is the CTO of Diality. From their base in California, Diality is redefining home dialysis, enabling patients in Kidney failure to undergo hemodialysis, in their own home. An engineer and technical management professional by background, Calyton specializes in new product and technology development and process scale-up.
https://www.linkedin.com/in/claytonpoppe/Alex Gilbert has worked within the Digital Health Industry for a number of years alongside healthcare, pharmaceutical and tech organisations. He joined Huma (previously called Medopad) as one of their first employees and currently manages global Life Sciences Partnerships and Digital Medicine development. Huma is one of the UK’s highest-growth digital health companies, having raised over 50 Million in funding, whilst partnering with Apple and Tencent. His passion is the use of technology to empower and engage the patient to take control of their care.
https://www.linkedin.com/in/alexgilberthuma/The Technology Partnership is where scientists & engineers develop new products & technologies that bring innovation & value to clients.
Find out more about our work here: https://www.ttp.com/ -
What is pain? Where does it start and end? In the mind, nerve endings, or somewhere else? In this final episode of the first season of Invent: Health from TTP, we’ll be exploring the many and varied facets of this most essential of human experiences. Speaking with specialists in the fields of psychology and neuroscience, we’ll find out what is being done to measure pain, to mitigate its severity and what the future of pain relief looks like, to see if people involved in healthcare and drug delivery should be giving pain more attention in their work.
Find out more on this week's episode of Invent: Health from TTP.
This Week's Guests
Dan Lock is a consultant in psychology and human factors at TTP. A psychologist by background, Dan leads on understanding the users of our products, exploring their motivations and figuring out those design features that translate into long-term adherence to medication.
https://www.linkedin.com/in/danlock/Dr. Hannah Claridge is a Neural Interfaces specialist here at TTP who, after a Master’s degree in Physics and a Ph.D. in Clinical Neurosciences from the University of Oxford, now specialises in neurotechnology and biosensing, developing clinical technologies for some of the world’s largest Med Tech companies and ambitious startups.
https://www.linkedin.com/in/hannah-claridgeDr. David Cottenden is a consultant here at TTP. He holds a Masters Degree in Mathematics from Cambridge University and a PHD in biomechanics from UCL. David's work has encompassed everything from developing medical devices to exploring and mapping pain in drug delivery.
https://www.linkedin.com/in/david-cottenden-7661b64b/The Technology Partnership is where scientists & engineers develop new products & technologies that bring innovation & value to clients.
Find out more about our work here: https://www.ttp.com/ -
Hello and welcome to Invent: Health, a podcast from technology and product development company TTP.
Invent: Health is a podcast about the future of health and technology, hosted by TTP Design and Strategy consultant, Matt Millington. Each week, we’ll be joined by the top scientists, designers, business leaders and academics working at the vanguard of this vital industry, to give you a behind-the-scenes look at the world of health tech.
See you soon!
-
We’re currently taking a short hiatus after our first season, where we covered everything from curing blindness to controlling pain; from making hospitals more sustainable to putting a hospital in your home. Before we come back with season two, our friends over at the Life Sciences team here at TTP are going to be dropping their very own series in the new year.
Invent: Life Sciences will be a series looking at all things biology - the efficacy of animal testing, the benefits of synthetic biology, even asking what the infamous team behind Theranos actually got right in terms of diagnostics.
But in the meantime, we wanted to give you some bonus content to whet your appetite for things to come and spread a bit of Christmas cheer. So here’s the full conversation from one of our favourite interviews of this series. In early November, we spoke with Dr. Pearse Keane for our episode on eyecare, looking at how the world’s top doctors and scientists are working to find ways to restore sight.
Dr. Pearse Keane is a consultant ophthalmologist at Moorfields Eye Hospital, London, and an associate professor at UCL Institute of Ophthalmology. In 2016, he initiated a formal collaboration between Moorfields Eye Hospital and Google DeepMind, with the aim of developing artificial intelligence (AI) algorithms for the earlier detection and treatment of retinal disease. In May 2020, he jointly led work, again published in Nature Medicine, to develop an early warning system for age-related macular degeneration (AMD), by far the commonest cause of blindness in many countries. In October 2019, he was included on the Evening Standard Progress1000 list of most influential Londoners and in 2020 he was listed on the “The Power List” by The Ophthalmologist magazine, a ranking of the Top 100 most influential people in the world of ophthalmology.
https://www.linkedin.com/in/pearse-keane-27074a6
